Evaluation of the antiulcerogenic activity of violacein and its modulation by the inclusion complexation with β-cyclodextrin

Canadian Journal of Physiology and Pharmacology

Volumn 81, Issue 4, 2003, Pages 387-396

  Durán, Nelson ^a,b   Justo, Giselle Z ^a   Melo, Patrícia S ^a   De Azevedo, Mariângela B M ^a   Souza Brito, Alba R M ^a   Almeida, Ana B A ^a   Haun, Marcela ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

Author keywords

cyclodextrin; Gastric ulcer; Hepatocyte; Lipid peroxidation; Violacein

Indexed keywords

ALCOHOL; ANTIULCER AGENT; BETA CYCLODEXTRIN; CIMETIDINE; HYDROCHLORIC ACID; ILZATEC; INDOMETACIN; LANSOPRAZOLE; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG; VIOLACEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENTIATION; LIPID PEROXIDATION; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH ULCER; STRESS; X RAY POWDER DIFFRACTION;

ANIMALS; ANTI-ULCER AGENTS; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; CIMETIDINE; CYCLODEXTRINS; DISEASE MODELS, ANIMAL; ETHANOL; HEPATOCYTES; HYDROCHLORIC ACID; INDOLES; INDOMETHACIN; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MICE; RATS; RATS, WISTAR; STOMACH ULCER; STRESS; TERT-BUTYLHYDROPEROXIDE;

EID: 0037863996     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y03-033     Document Type: Article

References (74)

1. Ahmed, M.O., El-Gibaly, I., and Ahmed, S.M. 1998. Effect of cyclodextrins on the physicochemical properties and antimycotic activity of clotrimazole. Int. J. Pharm. 171: 111-121.
2. Al-Shabanah, O.A., Raza, M., Al-Harbi, M.M., Al-Bekairi, A.M., Al-Gharably, N.M., and Qureshi, S. 2000. Effect of ninhydrin on the biochemical and histopathological changes induced by ethanol in gastric mucosa of rats. Life Sci. 67: 559-566.
3. Atay, S., Tarnawski, A.S., and Dubois, A. 2000. Eicosanoids and the stomach. Prostaglandins Other Lipid Mediat. 61: 105-124.
4. Bibby, D.C., Davies, N.M., and Tucker, I.G. 2000. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int. J. Pharm. 197: 1-11.
5. Blandizzi, C., Natale, G., Gherardi, G., Lazzeri, G., Marveggio, C., Colucci, R., Carignani, D., and Del Tacca, M. 1999. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury. Dig. Dis. Sci. 44: 2039-2050.
6. Brunton, L.L. 1996. Fármacos para controle da acidez gástrica e tratamento de úlceras pepticas. In As bases farmacológicas da terapêutica. 9th ed. Edited by J.G. Hardman and L.E. Limbird. McGraw-Hill, México City, México. pp. 662-673.
7. Chatjigakis, A.K., Donzé, C., and Coleman, A.W. 1992. Solubility behavior of β-cyclodextrin in water/cosolvent mixtures. Anal. Chem. 64: 1632-1634.
8. Connors, K.A. 1997. The stability of cyclodextrin complexes in solution. Chem. Rev. 97: 1325-1358.
9. Croft, K.D. 1998. The chemistry and biological effects of flavonoids and phenolic acids. Ann. N.Y. Acad. Sci. 854: 435-442.
10. Das, D., Bandyopadhyay, D., Bhattacharjee, M., and Banerjee, R. 1997. Hydroxyl radical is the major causative factor in stress-induced gastric ulceration. Free Rad. Biol. Med. 23: 8-18.
11. De Azevedo, M.B.M., Alderete, J.B., Lino, A.C.S., Loh, W., Faljoni-Alario, A., and Durán, N. 2000a. Violacein/β-cyclodextrin inclusion complex formation studied by measurements of diffusion coefficient and circular dichroism. J. Incl. Phenom. Mol. Recognit. Chem. 37: 67-74.
12. De Azevedo, M.B.M., Alderete, J., Rodriguez, J.A., Souza, A.O., Rettori, D., Torsoni, M.A., Faljoni-Alario, A., Haun, M., and Durán, N. 2000b. Biological activities of violacein a new antitumoral indole derivative in an inclusion complex with β-cyclodextrin. J. Incl. Phenom. Mol. Recognit. Chem. 37: 93-101.
13. 2 receptor antagonist, in rats. Agents Action, 42: 149-152.
14. Durán, N., and Menck, C.F.M. 2001. Chromobacterium violaceum: a review of pharmacological and industrial perspectives. Crit. Rev. Microbiol. 27: 201-222.
15. Evangelista, S., and Meli, A. 1985. Influence of antioxidants and radical scavengers on ethanol-induced gastric ulcers in the rat. Gen. Pharmacol. 16: 285-286.
16. Florence, A.T., and Jani, P.U. 1994. Novel oral drug formulations. Their potential in modulating adverse effects. Drug Saf. 10: 233-266.
17. Glavin, G.B., and Szabo, S. 1992. Experimental gastric mucosal injury: laboratory models reveal mechanisms of pathogenesis and new therapeutic strategies. FASEB J. 6: 825-831.
18. Goa, K.L., and Monk, J.P. 1987. Enprostil: a preliminary review of its pharmacodynamics and pharmacokinetic properties and therapeutic efficacy in the treatment of peptic ulcer disease. Drugs, 3: 539-559.
19. Gracioso, J.S., Vilegas, W., Hiruma-Lima, C.A., and Souza Brito, A.R.M. 2002. Effects of tea from Turnera ulmifolia L. on mouse gastric mucosa support the Turneraceae as a new source of antiulcerogenic drugs. Biol. Pharm. Bull. 25: 487-491.
20. Gremse, D.A. 2001. Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses. Expert. Opin. Pharmacother. 2: 1663-1670.
21. Grover, J.K., and Vats, V. 1999. Proton pump inhibitors. Trop. Gastroenterol. 20: 16-28.
22. Guguen-Guillouzo, C., and Guillouzo, A. 1986. In Isolated and culture hepatocytes. Edited by A. Guillouzo and C. Guguen-Guillouzo. Les Editions INSERM, Paris, and John Libbey Eurotext, London. pp. 1-12.
23. Halliwell, B., and Gutteridge, J.M.C. 1999. In Free radicals in biology and medicine. 3rd ed. Clarendon Press, Oxford, U.K. pp. 1-936.
24. Hayden, L.J., Thomas, G., and West, G.B. 1978. Inhibitors of gastric lesions in the rat. J. Pharmacol. 30: 244-246.
25. Hiruma-Lima, C.A., Gracioso, J.S., Nunes, D.S., and, Souza Brito, A.R.M. 1999. Effects of an essential oil from the bark of Croton cajucara Benth. on experimental gastric ulcer models in rats and mice. J. Pharm. Pharmacol. 51: 341-346.
26. Hiruma-Lima, C.A., Gracioso, J.S., Rodriguez, J.A., Haun, M., Nunes, D.S., and Souza Brito, A.R.M. 2000. Gastroprotective effect essential oil from Croton cajucara Benth. (Euphorbiaceae). J. Ethnopharmacol. 69: 229-234.
27. Hiruma-Lima, C.A., Gracioso, J.S., Toma, W., Almeida, A.B.A., Paula, A.C.B., Brasil, D.S.B., Müller, A.H., and Souza Brito, A.R.M. 2001. Gastroprotective effect of aparisthman, a diterpene isolated from Aparisthmium cordatum, on experimental gastric ulcer models in rats and mice. Phytomedicine, 8: 94-100.
28. Hiruma-Lima, C.A., Toma, W., Gracioso, J.S., Almeida, A.B.A., Batista, L.M., Magri, L., Paula, A.C.B., Soares, F.R., Nunes, D.S., and Souza Brito, A.R.M. 2002. Natural trans-crotonin: the antiulcerogenic effect of another diterpene isolated from the bark of Croton cajucara Benth. Biol. Pharm. Bull. 25: 452-456.
29. Horáková, L., and Stolc, S. 1998. Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen. Pharmac. 30: 627-638.
30. Ito, M., Inaguma, K., Suzuki, Y., Segami, T., and Suzuki, Y. 1995. Healing-promoting action of zinc-cimetidine complex on acetic acid-induced gastric ulcers in rats. Jpn. J. Pharmacol. 68: 287-295.
31. Ito, M., Suzuki, Y., Ishihara, M., and Suzuki, Y. 1998. Anti-ulcer effects of antioxidants: effect of probucol. Eur. J. Pharmacol. 354: 189-196.
32. Joyeux, M., Rolland, A., Fleurentin, J., Mortier, F., and Dorfman, P. 1990. Tert-butyl hydroperoxide-induced injury in isolated rat hepatocytes: a model for studying anti-hepatotoxic crude drugs. Planta Med. 56: 171-174.
33. Kaneko, T., and Baba, N. 1999. Protective effect of flavonoids on endothelial cells against linoleic acid hydroperoxide-induced toxicity. Biosci. Biotechnol. Biochem. 6: 323-328.
34. Kovacs, T.O., Campbell, D., Haber, M., Rose, P., Jennings, D.E., and Richter, J. 1998. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in maintenance of healed gastric ulcer. Dig. Dis. Sci. 43: 779-785.
35. Levine, R.J. 1971. A method for rapid production of stress ulcer in rats. In Peptic ulcer. Edited by C.J. Pfeiffer. Munksgaard, Copenhagen. pp. 92-97.
36. Lewis, D.A., and Hanson, P.J. 1991. In Progress in medicinal chemistry. Edited by G.P. Ellis and G.B. West. Elsevier Science Publishers, Amsterdam. pp. 201-231.
37. Lien, E.J., Ren, S., Bui, H.H., and Wang, R. 1999. Quantitative structure-activity relationship analysis of phenolic antioxidants. Free Rad. Biol. Med. 26: 285-294.
38. Ligumsky, M., Sestieri, M., Okon, M., and Ginsburg, I. 1995. Antioxidants inhibit ethanol-induced gastric injury in the rat. Role of manganese, glycine, and carotene. Scand. J. Gastroenterol. 30: 854-60.
39. Lissi, E.A., Faure, M., Montoya, N., and Videla, L.A. 1991. Reactivity of indole derivatives towards oxygenated radicals. Free Radical Biol. Commun. 15: 211-222.
40. Loftsson, T., and Brewster, M.E. 1996. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sciences, 85: 1017-1025.
41. Malterud, K.E., Diep, O.H., and Sund, R.B. 1996. C-methylated dihydrochalcones from Myrica gale L: effects as antioxidants and as scavengers of 1,1-diphenyl-2-picrylhydrazyl. Pharmacol. Toxicol. 78: 111-116.
42. McGuigan, J.E. 1991. Peptic ulcer and gastritis. In Harrison's principles of internal medicine. 12th ed. Edited by J.D. Wilson, E. Braun Wald, K.J. Isselbacher, R.G. Petersdorf, J.B. Martin, A.S. Fauchi, and R.K. Root. McGraw-Hill, New York. pp. 1229-1243.
43. Mirossay, L., and Kohút, A. 1991a. Antiulcerogenic effect of pentacaine, chlorpromazine and stobadine on ethanol- and indomethacin-induced stomach lesions in rats. Physiol. Pharmacol. 40: 441-444.
44. Mirossay, L., and Kohút, A. 1991b. Effect of stobadine on indomethacin- and ethanol-induced stomach lesions and gastric secretion. Physiol. Phramacol. 40: 437-440.
45. Mizui, T., and Doteuchi, M. 1983. Effect of polyamines on acidified ethanol-induced gastric lesion in rats. Jpn. Pharmacol. 33: 939-945.
46. Mizui, T., and Doteuchi, M. 1986. Lipid peroxidation: a possible role in gastric damage induced by ethanol in rats. Life Sci. 38: 2163-2167.
47. Mizui, T., Sato, H., Hirose, F., and Doteuchi, M. 1987. Effect of antioxidants drugs on gastric damage induced by ethanol in rats. Life Sci. 41: 755-763.
48. Mura, P., Faucci, M.T., Parrini, P.L., Furlanetto, S., and Pinzauti, S. 1999. Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems. Int. J. Pharm. 179: 117-128.
49. Olfert, E.D., Cross, B.M., and McWilliam, A.A. 1993. Guide to the care and use of experimental animals. Vol. 1. Canadian Council on Animal Care. Ottawa. pp. 1-213.
50. Phull, P.S., Green, C.J., and Jacyna, M.R. 1995. A radical view of the stomach: the role of oxygen-derived free radicals and antioxidants in gastroduodenal disease. Eur. J. Gastroenterol. Hepatol. 7: 265-274.
51. Ren, X., Xue, Y., Liu, J., Zhang, K., Zheng, J., Luo, G., Guo, C., Mu, Y., and Shen, J. 2002. A novel cyclodextrin-derived tellurium compound with glutathione peroxidase. Chembiochem. 3: 356-363.
52. Rettori, R., and Durán, N. 1998. Production, extraction and purification of violacein: an antibiotic pigment produced by Chromobacterium violaceum. World J. Microbiol. Biotechnol. 14: 685-688.
53. Robert, A., Nezamis, J.E., Lancaster, C., and Hanchar, A.J. 1979. Cytoprotection by prostaglandins in rats. Prevention of gastric necroses produced by alcohol, HCl, NaOH, hypotonic and thermal injury. Gastroenterology, 77: 433-443.
54. Robert, A., Lancaster, C., Davis, J.P., Field, J.P., and Nezamis, J.E. 1984. Distinction between antiulcer effect and cytoprotection. Scand. J. Gastroenterol. 101: 69-73.
55. Scheiman, J. 1998. Agents used in the prevention and treatment of nonsteroidal anti-inflammatory drug-associated symptoms and ulcers. Am. J. Med. 105: 32S-38S.
56. Shii, D., Inaguma, K., Ito, M., and Suzuki, Y. 1992. Role of oxygen radicals in healing process of acetic acid-induced ulcers in rats with limited food-intake-time and effects of oxygen radical scavengers on the healing. Exp. Ulcer, 19: 105-109.
57. Souza Brito, A.R.M. 1996. How to study the pharmacology of medicinal plants in underdeveloped countries. J. Ethnopharmacol. 54: 131-138.
58. Souza Brito, A.R.M., Rodriguez, J.A., Hiruma-Lima, C.A., Haun, M., and Nunes, D.S. 1998. Anti-ulcerogenic activity of dehydrocrotonin, a diterpene isolated from Croton cajucara Benth. Planta Med. 64: 126-129.
59. Stella, V.J., and Rajewski, R.A. 1997. Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 14: 556-567.
60. Stella, V.J., Rao, V.M., Zannou, E.A., and Zia, V.V. 1999. Mechanisms of drug release from cyclodextrin complexes. Adv. Drug Deliv. Rev. 36: 3-16.
61. Szejtli, J. 1994. Medicinal applications of cyclodextrins. Med. Res. Rev. 14: 353-386.
62. Szejtli, J., Bolla-Pusztai, E., Tardy-Lengyel, M., and Szabo, P. 1983. Preparation, properties and biological activity of β-cyclodextrin inclusion complex of menadione. Pharmazie, 38: 189-193.
63. Szelenyi, I., and Thiemer, K. 1978. Distention ulcer as a model for testing of drugs for ulcerogenic side effects. Arch. Toxicol. 41: 99-105.
64. Terano, A., Hiraishi, H., Ota, S., Shiga, J., and Sugimoto, T. 1989. Role of superoxide and hydroxyl radicals in rat gastric mucosal injury induced by ethanol. Gastroenterol. Jpn. 24: 488-493.
65. Thompson, D.O. 1997. Cyclodextrins enabling excipients: their present and future use in pharmaceuticals. Crit. Rev. Ther. Drug Carrier Syst. 14: 1-104.
66. Toma, W., Gracioso, J.S., Andrade, F.D.P., Hiruma-Lima, C.A., Vilegas, W., and Souza Brito, A.R.M. 2002. Antiulcerogenic activity of four extracts obtained from the bark wood of Quassia amara L. (Simaroubaceae). Biol. Pharm. Bull. 25: 1151-1155.
67. Uekama, K., Hirayama, F., and Irie, T. 1998. Cyclodextrin drug carrier systems. Chem. Rev. 98: 2045-2076.
68. Vane, J.R., and Botting, R.M. 1995. New insights into the mode of action of anti-inflammatory drugs. Inflamm. Res. 44: 1-10.
69. Vora, J., and Boroujerdi, M. 1995. Enhanced aqueous solubility of phenolic antioxidants using modified beta-cyclodextrin. Drug Develop. Ind. Pharm. 21: 495-502.
70. Wallace, J.L. 2001. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Mechanisms of protection and healing: current knowledge and future directions. Am. J. Med. 110: 19S-23S.
71. Wallace, J.L., and Granger, D.N. 1996. The cellular and molecular basis of gastric mucosal defense. FASEB J. 10: 731-740.
72. Wallace, J.L., and Ma, L. 2001. Inflammatory mediators in gastrointestinal defense and injury. Exp. Biol. Med. 226: 1003-1115.
73. Yoshikawa, T., Naito, Y., Kishi, A., Tomii, Y., Kaneko, T., Iinuma, S., Ichikawa, H., Yasuda, M., Takahashi, S., and Kondo, M. 1993. Role of active oxygen lipid peroxidation and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut, 34: 732-737.
74. Zimmermann, A.E., and Katona, B.G. 1997. Lansoprazole: a comprehensive review. Pharmacotherapy, 17: 308-326.